Clinical efficacy and safety of linezolid in intensive care unit patients.

Ma, Aijia; Dong, Meiling; Cheng, Jiangli; Liao, Xuelian; Dong, Wei; Liu, Chang; Hu, Chenggong; Yang, Jing; Kang, Yan

Ma, Aijia; Dong, Meiling; Cheng, Jiangli; Liao, Xuelian; Dong, Wei; Liu, Chang; Hu, Chenggong; Yang, Jing; Kang, Yan.

Afiliación

Ma A; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Dong M; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Cheng J; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Liao X; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Dong W; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Liu C; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Hu C; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Yang J; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Kang Y; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.

J Intensive Med ; 3(1): 65-72, 2023 Jan 31.

Article en En | MEDLINE | ID: mdl-36789359

Palabras clave

Gram-positive bacterial infection; Intensive care unit; Linezolid; Real-world study

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Intensive Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google